Medical Portfolio Podcast

Medical Portfolio Podcast: Best of the Month - October 2025

20 min · 13. marras 2025
jakson Medical Portfolio Podcast: Best of the Month - October 2025 kansikuva

Kuvaus

Join our scientific team in the discussion of the 3 most clinically impactful papers of the month, the crème de la crème of our weekly top picks. This month we’re discussing:Left bundle branch area pacing vs right ventricular pacing in preserved or mildly reduced ejection fraction: the PACE-HF trialDOI: https://doi.org/10.1093/eurheartj/ehaf724Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trialDOI: https://doi.org/10.1016/S0140-6736(25)01375-3An AI-Powered Lifestyle Intervention vs Human Coaching in the Diabetes Prevention Program: A Randomized Clinical TrialDOI: https://doi.org/10.1001/jama.2025.19563Scientific team:Ricardo Ladeiras Lopes, Mário Santos and João Sérgio NevesDiscover Medical Portfolio App weekly top picks - the latest and most relevant papers, curated by our team of experts! ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://linktr.ee/medicalportfolioapp⁠⁠

Kommentit

0

Ole ensimmäinen kommentoija

Rekisteröidy nyt ja liity Medical Portfolio Podcast-yhteisöön!

Aloita maksutta

14 vrk ilmainen kokeilu

Kokeilun jälkeen 7,99 € / kuukausi. · Peru milloin tahansa.

  • Podimon podcastit
  • 20 kuunteluaikaa / kuukausi
  • Lataa offline-käyttöön

Kaikki jaksot

54 jaksot

jakson Medical Portfolio Podcast: Best of the Month - November 2025 kansikuva

Medical Portfolio Podcast: Best of the Month - November 2025

Join our scientific team in the discussion of the 3 most clinically impactful papers of the month, the crème de la crème of our weekly top picks. This month we’re discussing: #1 - Triple Versus Dual Lipid-Lowering Therapy in Acute Coronary Syndrome: The ES-BempeDACS Randomized Clinical TrialDOI: https://doi.org/10.1093/eurheartj/ehaf724 #2 - Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial DOI: 10.1056/NEJMoa2509688 #3 - Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial DOI: 10.1016/S0140-6736(25)02155-5 Scientific team:Ricardo Ladeiras Lopes, Mário Santos and João Sérgio Neves Discover Medical Portfolio App weekly top picks - the latest and most relevant papers, curated by our team of experts! ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://linktr.ee/medicalportfolioapp⁠⁠

16. joulu 202528 min
jakson Medical Portfolio Podcast: Best of the Month - October 2025 kansikuva

Medical Portfolio Podcast: Best of the Month - October 2025

Join our scientific team in the discussion of the 3 most clinically impactful papers of the month, the crème de la crème of our weekly top picks. This month we’re discussing:Left bundle branch area pacing vs right ventricular pacing in preserved or mildly reduced ejection fraction: the PACE-HF trialDOI: https://doi.org/10.1093/eurheartj/ehaf724Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trialDOI: https://doi.org/10.1016/S0140-6736(25)01375-3An AI-Powered Lifestyle Intervention vs Human Coaching in the Diabetes Prevention Program: A Randomized Clinical TrialDOI: https://doi.org/10.1001/jama.2025.19563Scientific team:Ricardo Ladeiras Lopes, Mário Santos and João Sérgio NevesDiscover Medical Portfolio App weekly top picks - the latest and most relevant papers, curated by our team of experts! ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://linktr.ee/medicalportfolioapp⁠⁠

13. marras 202520 min
jakson Medical Portfolio Podcast: Best of the Month - September 2025 kansikuva

Medical Portfolio Podcast: Best of the Month - September 2025

Join our scientific team in the discussion of the 3 most clinically impactful papers of the month, the crème de la crème of our weekly top picks.This month we’re discussing:Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trialDOI: https://doi.org/10.1016/S0140-6736(25)01665-4Increasing the Potassium Level in Patients at High Risk for Ventricular ArrhythmiasDOI: ⁠https://doi.org/⁠10.1056/NEJMoa2509542Comparison of an Energy-Reduced Mediterranean Diet and Physical Activity Versus an Ad Libitum Mediterranean Diet in the Prevention of Type 2 Diabetes: A Secondary Analysis of a Randomized Controlled TrialDOI: https://doi.org/10.7326/ANNALS-25-00388Scientific team:Ricardo Ladeiras Lopes, Mário Santos and João Sérgio NevesDiscover Medical Portfolio App weekly top picks - the latest and most relevant papers, curated by our team of experts! ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://linktr.ee/medicalportfolioapp⁠⁠

14. loka 202527 min